Literature DB >> 16637557

Neonatal liver disease.

Karan McBride Emerick1, Peter F Whitington.   

Abstract

Establishing a rapid and accurate diagnosis of the cause of neonatal liver disease is an urgent matter. The initial detection of this condition relies on the sensitivity of the primary care provider or pediatrician to the signs and symptoms of jaundice and abnormal stool and urine color. It is critical to evaluate jaundice in any infant older than 2 weeks with measurement of fractionated bilirubin, and further assessment is necessary if the direct value is above 1.0 mg/dL in the setting of a total bilirubin of less than 5.0 mg/dL or a direct bilirubin of more than 20% of total if the total is more than 5.0 mg/dL. A diagnostic algorithm for the evaluation of infants who meet these criteria can guide physicians in selecting appropriate and timely diagnostic testing and referral to pediatric gastroenterology for these patients, whose outcome will rely on rapid diagnosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16637557     DOI: 10.3928/0090-4481-20060401-13

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  8 in total

1.  Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.

Authors:  Tamara N Pereira; Meagan J Walsh; Peter J Lewindon; Grant A Ramm
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

2.  Incidence and Risk Factors of Parenteral Nutrition-Associated Cholestasis in Omani Neonates: Single centre experience.

Authors:  Sharef W Sharef; Siham Al-Sinani; Khalid Al-Naamani; Ibrahim Al-Zakwani; Zenaida S Reyes; Hilal Al-Ryiami; Ashfaq A Khan; Watfa Al-Mamari
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

3.  Biopsy-driven diagnosis in infants with cholestatic jaundice in Iran.

Authors:  Elham Talachian; Ali Bidari; Mitra Mehrazma; Nahid Nick-khah
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

4.  TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse.

Authors:  Alisan Kahraman; Fernando J Barreyro; Steven F Bronk; Nathan W Werneburg; Justin L Mott; Yuko Akazawa; Howard C Masuoka; Charles L Howe; Gregory J Gores
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

5.  Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants.

Authors:  Maissa Rayyan; Hugo Devlieger; Frank Jochum; Karel Allegaert
Journal:  JPEN J Parenter Enteral Nutr       Date:  2012-01       Impact factor: 4.016

6.  Evaluation of cholestasis in Iranian infants less than three months of age.

Authors:  Seyed Mohsen Dehghani; Neda Efazati; Iraj Shahramian; Mahmood Haghighat; Mohammad Hadi Imanieh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

7.  Successful Outcome and Biliary Drainage in an Infant with Concurrent Alpha-1-Antitrypsin Deficiency and Biliary Atresia.

Authors:  Andrew W Wang; Kimberly Newton; Karen Kling
Journal:  Case Rep Surg       Date:  2017-11-29

8.  Biliary atresia: 50 years after the first kasai.

Authors:  Barbara E Wildhaber
Journal:  ISRN Surg       Date:  2012-12-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.